BUSINESS DEVELOPMENT TRANSACTION
Business development is vital for bridging scientific innovation with commercial success in the healthcare industry. We support companies in strategically planning and executing partnerships, from co-development to commercial collaborations. We also specialize in in-licensing and out-licensing assets, managing the entire deal processes, including market analysis, target identification, partner outreach, and negotiation, to ensure successful transactions.
In recent years, Japan has taken significant steps to ease regulatory requirements to reduce drug lag and drug loss.
At Swanielle, we help global pharmaceutical companies strategically integrate Japan into their global drug development plans from the earliest stages.
Our team supports key decision-making processes by offering expert guidance on:
- Leading PMDA consultations on behalf of clients and designing development strategies aligned with Japanese regulatory expectations
- Analyzing potential National Health Insurance (NHI) reimbursement prices
- Conducting comprehensive commercialization assessments tailored to the Japanese market
With a deep understanding of Japan’s evolving regulatory and market landscape, we enable our clients to navigate complexity and accelerate patient access to innovative therapies.
HANDS ON CONSULTING
Hands-On Commercial Consulting for the Healthcare Sector
We provide hands-on consulting services in the healthcare industry, with a strong focus on the commercial side of pharmaceutical business operations.
Our team consists of experienced consultants with deep expertise in marketing, digital marketing, pricing & market access, public affairs, medial affairs, business IT, and training — all with a strong track record in the pharmaceutical industry.
Unlike traditional consulting firms that offer only strategic advice, we work alongside our clients to execute and implement. From planning to hands-on delivery, we support real-world results.